MedPath

Quelicin

QUELICIN (Succinylcholine Chloride Injection, USP)

Approved
Approval ID

7988b85a-d884-1885-e053-2991aa0afc87

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 24, 2020

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Succinylcholine Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7146
Application NumberNDA008845
Product Classification
M
Marketing Category
C73594
G
Generic Name
Succinylcholine Chloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 24, 2020
FDA Product Classification

INGREDIENTS (6)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
METHYLPARABENInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
SUCCINYLCHOLINE CHLORIDEActive
Quantity: 20 mg in 1 mL
Code: I9L0DDD30I
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Quelicin - FDA Drug Approval Details